The White House is reportedly considering a waiver of intellectual property rights on the production of COVID-19 vaccines. Press Secretary Jen Psaki on Tuesday said that the US wants to maximise the global production of COVID-19 vaccines at the lowest cost, even though no decision has been made on the waiver yet.

US reportedly considering intellectual property waiver for coronavirus vaccines

Pushing against the proposed Intellectual Property (IP) waiver for Covid vaccines, Pharma companies are saying that removing IP protections from Covid-19 vaccines or pressuring companies into technology sharing will not speed up production of the jabs.

Vaccine makers oppose IP waiver, say manufacturing hurdles slowing rollout

ip-waiver

Ip Waiver, News on Ip Waiver, stories on Ip Waiver, articles on Ip Waiver, Ip Waiver stories at Wion, Ip Waiver news, Ip Waiver latest news

ip waiver

US reportedly considering intellectual property waiver for coronavirus vaccines

Vaccine makers oppose IP waiver, say manufacturing hurdles slowing rollout